Physician profile
Anum Abbasi
NPI 1679063010
$2,032.17
in general payments reported to CMS, 2019-2025
20 companies · $619 in 2025
The $619 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $160 · 2023: $749 · 2024: $504 · 2025: $619.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,872.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,871.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $407.63 | 2023-2025 | Liletta, Lo Loestrin Fe, Orilissa |
| Organon LLC | $269.14 | 2022-2025 | Nexplanon, Jada System |
| Mayne Pharma Commercial LLC | $184.99 | 2023-2025 | |
| Coopersurgical, INC. | $147.46 | 2023-2025 | Paragard T 380a, Paragard T 380a |
| Exeltis, USA INC. | $139.70 | 2022-2025 | Slynd |
| Daiichi Sankyo INC. | $107.63 | 2023 | Injectafer |
| Astellas Pharma US INC | $98.40 | 2024-2025 | Veozah |
| Biogen, INC. | $92.95 | 2025 | Zurzuvae |
| Exact Sciences Corporation | $90.19 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Medtronic, INC. | $80.41 | 2022 | |
| Novo Nordisk INC | $75.48 | 2025 | Wegovy |
| Pfizer INC. | $55.82 | 2023-2024 | |
| Sumitomo Pharma America, INC. | $55.25 | 2024 | Gemtesa, Myfembree |
| Pacira Pharmaceuticals Incorporated | $48.27 | 2025 | Exparel |
| Vertex Pharmaceuticals Incorporated | $44.34 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $43.56 | 2024-2025 | Intrarosa, Femring |
| Bluewind Medical | $26.59 | 2025 | Revi |
| Agile Therapeutics, INC. | $25.57 | 2024 | Twirla |
| Bayer Healthcare Pharmaceuticals INC. | $23.00 | 2022 | |
| Heron Therapeutics, INC. | $15.79 | 2023 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anum Abbasi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.